BRD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.30979712923363E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.63539999992391E-07 |
Normal-vs-Stage2 |
7.95260000000519E-05 |
Normal-vs-Stage3 |
8.11749556461905E-11 |
Normal-vs-Stage4 |
1.07459996456782E-09 |
Stage1-vs-Stage2 |
3.440000E-01 |
Stage1-vs-Stage3 |
3.163600E-04 |
Stage1-vs-Stage4 |
1.016620E-03 |
Stage2-vs-Stage3 |
2.653000E-01 |
Stage2-vs-Stage4 |
2.127400E-01 |
Stage3-vs-Stage4 |
7.835400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.82549531047016E-11 |
Normal-vs-AfricanAmerican |
7.826100E-04 |
Normal-vs-Asian |
5.707800E-01 |
Caucasian-vs-AfricanAmerican |
1.715800E-01 |
Caucasian-vs-Asian |
7.172500E-02 |
AfricanAmerican-vs-Asian |
2.925400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.17019949286146E-10 |
Normal-vs-Female |
3.89640000264535E-08 |
Male-vs-Female |
5.624200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.437100E-03 |
Normal-vs-Age(41-60Yrs) |
6.81730000007263E-07 |
Normal-vs-Age(61-80Yrs) |
5.47450973442665E-12 |
Normal-vs-Age(81-100Yrs) |
7.93110000008035E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.219000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.406200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.850500E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.608200E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.887610E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.928000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.615000E-01 |
Normal-vs-Grade 2 |
2.22299999999009E-05 |
Normal-vs-Grade 3 |
4.49980053218724E-11 |
Normal-vs-Grade 4 |
1.22640009259101E-10 |
Grade 1-vs-Grade 2 |
5.036000E-02 |
Grade 1-vs-Grade 3 |
4.30940000000213E-05 |
Grade 1-vs-Grade 4 |
1.186090E-04 |
Grade 2-vs-Grade 3 |
3.67150000000205E-05 |
Grade 2-vs-Grade 4 |
2.443900E-04 |
Grade 3-vs-Grade 4 |
2.786600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.03550000036302E-07 |
Normal-vs-ccB subtype |
3.12350001419048E-09 |
ccA subtype-vs-ccB subtype |
8.314300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.73050051855262E-10 |
Normal-vs-N1 |
1.318430E-03 |
N0-vs-N1 |
6.832600E-01 |
|
|